El Salvador Achieves Historic Trachoma Elimination, First in Central America to Eradicate Blinding

A significant public health triumph has been declared in Central America, as the World Health Organization (WHO) officially validated El Salvador for eliminating trachoma as a public health problem. This achievement marks a crucial step forward in the global fight against preventable blindness, solidifying El Salvador's place as a pioneer in regional health initiatives and offering a powerful blueprint for other nations.

Quick summary

• El Salvador has been validated by the WHO as having eliminated trachoma, the world's leading infectious cause of blindness, as a public health problem.
• The milestone follows a rigorous multi-year assessment (2023-2026) that confirmed no active transmission or advanced cases of the disease within the country.
• El Salvador is the first country in Central America and the second in the Americas, after Mexico, to achieve this significant public health certification for trachoma.
• Success is attributed to a robust multisectoral approach encompassing strengthened primary health care, improved water, sanitation, and hygiene (WASH) services, and dedicated eye health programs, supported by PAHO and Canada.

Why it matters

The elimination of trachoma in El Salvador carries profound implications beyond its borders. For the Salvadoran population, particularly those in vulnerable communities often disproportionately affected, it means a future free from a debilitating disease that can lead to irreversible blindness, significantly improving quality of life and economic productivity. This success provides a tangible model for other nations still grappling with neglected tropical diseases (NTDs), demonstrating that with sustained political will, strategic investment, and community engagement, even long-standing health challenges can be overcome. It injects vital momentum into the WHO’s ambitious global target of eliminating trachoma worldwide by 2030 and strengthens the Pan American Health Organization’s (PAHO) regional initiative to eliminate over 30 communicable diseases by the same deadline, serving as a beacon of hope and a blueprint for integrated health interventions.

Background

Trachoma, caused by the bacterium Chlamydia trachomatis, has historically been the leading infectious cause of blindness globally. Transmitted through contact with eye and nasal discharge from infected individuals, repeated infections lead to scarring of the inner eyelid, causing eyelashes to turn inward—a painful condition known as trichiasis—which eventually abrades the cornea and results in permanent blindness. The disease is intrinsically linked to poverty and inequities in access to fundamental services like clean water, sanitation, and adequate healthcare. Recognising this devastating impact, the WHO launched the Alliance for the Global Elimination of Trachoma by 2020 (GET2020) in 1996, creating a collaborative network of governments, non-governmental organizations, and academic institutions. While the 2020 target was not met globally, the initiative laid the groundwork for persistent efforts. Regionally, PAHO has been spearheading the Initiative for the Elimination of Trachoma in the Americas, supporting countries like El Salvador that were previously considered areas where the disease might be endemic or suspected. Until recent assessments provided definitive evidence, El Salvador was among those nations, making its journey from a potential endemic zone to validated elimination a testament to focused public health action.

Qnews24h insight

El Salvador’s triumph over trachoma is not merely a medical achievement; it represents a powerful validation of comprehensive public health strategies that prioritize equity and integrated care. This success story underscores the critical importance of a "health in all policies" approach, where improvements in water, sanitation, and hygiene (WASH) are seen as integral to disease prevention, alongside robust primary health care and targeted ophthalmic services. The rapid three-year timeframe from initial assessments (2023) to validation (2026) highlights that focused, evidence-based interventions can yield swift and impactful results. Furthermore, the commitment to establishing sustained surveillance mechanisms post-elimination is crucial, demonstrating foresight against re-emergence. This model offers invaluable lessons for other nations tackling NTDs, emphasizing that political will, community buy-in, and international collaboration are not just aspirational goals but essential components for transforming public health outcomes in even the most resource-constrained settings. It sets a high bar and provides a practical roadmap for the global community's 2030 disease elimination targets.

The Path to Elimination: A Multisectoral Approach

El Salvador’s journey to becoming trachoma-free was meticulously planned and executed, spanning a multi-year effort that culminated in rigorous assessments between 2023 and 2026. The validation process, orchestrated by the WHO, involved a comprehensive review to ascertain the absence of trachoma as a public health threat and to evaluate the national health system's capacity for ongoing detection, investigation, and response. Targeted community assessments were conducted in areas identified with higher environmental and social risk factors. Crucially, these investigations yielded no evidence of active trachoma transmission, with no signs of the disease detected in children aged 1-9 years, and no advanced cases of trichiasis – the blinding stage – found among adults.

This conclusive data affirmed that trachoma no longer posed a public health challenge within the nation’s borders. This success was not serendipitous but the direct outcome of a deliberate, multisectoral strategy. The Salvadoran government, with support from the Pan American Health Organization (PAHO) and the Government of Canada, implemented an integrated approach that bolstered primary health care services across the country. Key components included significant improvements in water, sanitation, and hygiene (WASH) infrastructure and practices, which are fundamental in preventing the spread of the bacterium Chlamydia trachomatis.

Strengthening Eye Health and Community Engagement

Alongside foundational public health improvements, specialized eye health services were enhanced, incorporating visual acuity screenings for adults to identify and manage any existing vision impairments or early signs of ocular diseases. The collaboration extended beyond government sectors, fostering strong partnerships with communities themselves and international organizations. This holistic strategy ensured that vulnerable populations, often the most affected by neglected tropical diseases, were actively reached and included in the health interventions.

The Minister of Health for El Salvador, Francisco Alabi, expressed immense pride in the achievement, noting, "We are proud to have reached this achievement in just three years, positioning the country in the region and improving the visual health of our population." He credited the sustained national efforts, with critical backing from PAHO and the Embassy of Canada, for enabling this swift progress.

Sustaining the Achievement

Achieving elimination is a monumental task, but maintaining that status requires ongoing vigilance. El Salvador has proactively established robust systems to safeguard its accomplishment. This includes the training of health personnel to identify potential cases, the integration of surveillance mechanisms into the national health system, and the capacity to detect and manage any incident cases of trichiasis effectively. This forward-thinking approach ensures that if any isolated cases were to emerge, the country’s health infrastructure is prepared to swiftly address them, preventing any potential re-establishment of the disease as a public health concern. WHO recommendations emphasize such sustained surveillance and continued access to quality eye care to prevent re-emergence.

Trachoma: A Preventable Scourge of Poverty

Trachoma’s devastating impact is intrinsically linked to socio-economic conditions. The bacterium Chlamydia trachomatis thrives in environments where access to clean water, sanitation, and proper hygiene is limited. Poverty and inadequate basic services create a vicious cycle, where the disease exacerbates health disparities, further entrenching communities in destitution. Globally, neglected tropical diseases (NTDs), including trachoma, disproportionately affect impoverished communities in tropical and subtropical regions, leading to severe health, social, and economic consequences. El Salvador's success provides a powerful illustration that breaking this cycle is possible through targeted and equitable interventions.

A Regional and Global Fight Against Neglected Tropical Diseases

El Salvador’s validation marks a significant milestone not just for the country but for the entire Americas region. It stands as the first country in Central America and only the second in the Americas, following Mexico, to eliminate trachoma as a public health problem. This achievement is part of a broader regional push by PAHO, which has set an ambitious goal to eliminate over 30 communicable diseases, including NTDs like trachoma, in the Americas by 2030.

While El Salvador celebrates its victory, trachoma remains a public health problem in rural and remote areas of other American nations such as Brazil, Colombia, Guatemala, and Peru. Efforts are also underway to better define the epidemiological status of the disease in countries where it has been suspected, including Bolivia, Ecuador, Guyana, Panama, Paraguay, and Venezuela. These ongoing challenges underscore the importance of shared learning and collaboration across the region. Globally, El Salvador joins a growing list of countries — now 33 in total, including nations like Algeria, Australia, India, and Vietnam — that have been recognized by the WHO for eliminating trachoma. This collective progress contributes to the broader global roadmap for neglected tropical diseases 2021–2030, which defines public health targets for the control, elimination, and eradication of these conditions worldwide.

Setting the Standard: What Elimination Means

The WHO’s definition of trachoma elimination as a public health problem is stringent and multi-faceted. It requires:

• A prevalence of trachomatous trichiasis (TT) “unknown to the health system” of less than 0.2% in individuals aged 15 years and older.
• A prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years of less than 5%, in each formerly endemic district.
• The existence of a robust system to identify and manage new (incident) cases of TT effectively.

El Salvador's fulfillment of these criteria, confirmed through its comprehensive assessments, signifies not just the absence of the disease but also the presence of a resilient health system capable of maintaining this vital public health achievement. This validation reinforces the potential for widespread eradication of NTDs and moves the world closer to a healthier, more equitable future for all.

Sources

• World Health Organization (WHO) - "El Salvador validated by WHO as having eliminated trachoma as a public health problem"

FAQ

• What is trachoma and why is its elimination significant?
  Trachoma is the world's leading infectious cause of blindness, caused by the bacterium Chlamydia trachomatis. Repeated eye infections lead to scarring and inward-turning eyelashes (trichiasis), which eventually cause irreversible blindness. Its elimination is significant because it prevents widespread suffering, improves the quality of life for vulnerable populations, and contributes to global health equity and economic productivity, especially in communities linked to poverty.
• How did El Salvador achieve trachoma elimination?
  El Salvador employed a comprehensive multisectoral approach from 2023 to 2026. This included strengthening primary health care services, improving water, sanitation, and hygiene (WASH) infrastructure, enhancing eye health services, and fostering strong collaboration between government sectors, communities, and international partners like PAHO and the Government of Canada. Rigorous assessments confirmed no active transmission, leading to WHO validation.
• What does "elimination as a public health problem" mean for trachoma?
  According to the WHO, it means a country has met specific epidemiological targets: a prevalence of trachomatous trichiasis (TT) unknown to the health system of less than 0.2% in people aged 15 and above, and a prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years of less than 5% in former endemic districts. Crucially, it also requires the existence of a system to identify and manage any new cases of TT that may arise.
• What is the broader impact of El Salvador's achievement on global health?
  El Salvador's success provides a powerful blueprint and inspires other countries still struggling with trachoma and other neglected tropical diseases (NTDs). It demonstrates that with political commitment, strategic investment, and integrated health programs, these diseases can be overcome. This achievement significantly contributes to the WHO's global target of eliminating trachoma by 2030 and PAHO's regional initiative to eliminate over 30 communicable diseases in the Americas by the same year.